Malik Rajesh
- SEC CIK
- 0001706853
No open-market purchases or sales filed in the past year.
Current role at each company
- GTHX G1 Therapeutics, Inc.Chief Medical Officeras of Sep 18, 2024
- PNT POINT Biopharma Global Inc.Directoras of Dec 27, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Malik Rajesh as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GTHX G1 Therapeutics, Inc.
Chief Medical Officer10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2024 (view filing) | Jul 5 | 3 days | Malik RajeshChief Medical Officer | SSale | −2.48K | $2.51 | −$6.21K | −1.5%159.3K after | |
| May 15, 2024 (view filing) | May 13 | 2 days | Malik RajeshChief Medical Officer | SSale | −8.15K | $4.79 | −$39.0K | −4.8%161.8K after | |
| Feb 13, 2024 (view filing)6:14 PM ET | Feb 12 | 1 day | Malik RajeshChief Medical Officer | SSale | −28.6K | $4.62 | −$132.1K | −14.4%169.9K after | 10b5-1 |
| Jan 8, 2024 (view filing) | Jan 3-4 | 5 daysLate | Malik RajeshChief Medical Officer | SSale | −3.74K | $3.09 | −$11.5K | −2.2%169.9K after | 3 lots |
| Dec 13, 2023 (view filing)4:45 PM ET | Dec 11 | 2 days | Malik RajeshChief Medical Officer | SSale | −33.8K | $3.41 | −$115.5K | −19.9%136.4K after | 2 lots10b5-1 |
| Jul 7, 2023 (view filing) | Jul 5 | 2 days | Malik RajeshChief Medical Officer | SSale | −1.36K | $2.45 | −$3.33K | −1.0%136.4K after | 10b5-1 |
| Jan 5, 2023 (view filing) | Jan 4-5 | 1 day | Malik RajeshChief Medical Officer | SSale | −2.37K | $5.53 | −$13.1K | −2.3%102.7K after | 2 lots |
| Sep 16, 2022 (view filing)4:31 PM ET | Sep 13 | 3 daysLate | Malik RajeshChief Medical Officer | SSale | −18.0K | $15.71 | −$282.7K | −19.7%73.2K after | |
| Jul 6, 2022 (view filing) | Jul 5 | 1 day | Malik RajeshChief Medical Officer | SSale | −648 | $5.17 | −$3.35K | −0.9%73.2K after | |
| Jan 5, 2022 (view filing) | Jan 5 | Same day | Malik RajeshChief Medical Officer | SSale | −1.45K | $10.61 | −$15.3K | −2.2%63.9K after |
PNT POINT Biopharma Global Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 (view filing) | Nov 28 | Same day | Malik RajeshDirector | PPurchase | +3.70K | $6.66 | +$24.6K | New position3.70K after |